Leuprolide acetate and acetylcholinesterase inhibitors or...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/00 (2006.01)

Patent

CA 2590997

Methods of treating, mitigating, slowing the progression of, or preventing Alzheimer~s Disease include administration of gonadotropin-releasing hormone analogues in combination with acetylcholinesterase inhibitors and/or N-methyl- D- aspartate receptor antagonists.

Cette invention concerne des méthodes permettant de traiter, d'atténuer ou de prévenir la maladie d'Alzheimer ou de ralentir sa progression, lesquelles méthodes consistent à administrer des analogues de la gonadolibérine conjointement à des inhibiteurs de l'acétylcholinestérase et/ou à des antagonistes des récepteurs N-méthyl D-aspartate.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Leuprolide acetate and acetylcholinesterase inhibitors or... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Leuprolide acetate and acetylcholinesterase inhibitors or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Leuprolide acetate and acetylcholinesterase inhibitors or... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2042945

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.